BD Institute for Medication Management Excellence
Helping to advance the safe and efficient management of medications across the care continuum
The BD Institute for Medication Management Excellence works with customers and industry thought leaders to transform medication management in meaningful ways and engages others to join the effort. The goal is to identify and support evolutionary―and revolutionary―advancements by encouraging new ways of thinking, new methods, processes, guidelines and best practices to create a foundation for measurable improvements.
The institute strives to consistently deliver high impact thought leadership initiatives. It also works to engage with health systems, clinicians, technology partners, regulatory organizations and thought leaders to create a forum for insightful research and best practices to directly impact patient safety.
Key initiatives include:
Opioid Control and Management
Addressing clinical and operational medication management and drug diversion issues to define and promote solutions for the rising opioid epidemic in acute care settings.
End-to-end IV safety
Improving IV infusion safety from initial compounding all the way to administration at the bedside.
Medication availability
Ensuring the right medication is available when and where needed to improve patient outcomes and cost efficiencies across the continuum of care.
Educational Resources
Webinars
Join us for a series of webinars focused on managing intravenous therapies in the acute care setting
Intravenous therapy is an essential component of acute care. Patients may need intravenous therapy for fluid and electrolyte replacement, and the intravenous route of administration immediately affects patient status. As prevalent as intravenous therapy is, the procedure can be risky. In this webinar series, we will examine delivery processes, safety gaps and ways to fill the gaps to establish a systems approach to intravenous medication delivery.
Finding and Addressing the Gaps in the IV Medication Management Process
Errors involving IV medications can result in significant patient harm, given the immediate bioavailability and narrow therapeutic index of many drugs administered intravenously.
With likely more than 90% of hospitalized patients receiving some form of intravenous drug therapy during their stay, it is important for organizations to identify and address related vulnerabilities with IV medication use.
This webinar will focus on the multiple risks associated with intravenous medications and the need to adopt proven technologies and best practices to optimize safety.
The speaker will present an overview of error-reduction strategies for infusion therapy, including technologies that support IV compounding.
She will also discuss the value of adopting barcoding technology and smart infusion pumps integrated with the electronic health record (EHR) to promote safe IV medication preparation and administration.
Date: Wednesday, February 7, 2018
Time: 2:00 p.m.
ET, 60 minutes
Speaker: Michelle Mandrack, MSN, RN, Director of Consulting Services,
Institute for Safe Medication Practices
Continuing education
This activity, for one contact hour, is provided by BD Medical Clinical Resource Services Department, which is accredited as a provider of continuing education by the California Board of Registered Nursing, provider #CEP 13136.
This certificate must be retained by the attendee for a period of four years. If you are interested in receiving nursing credit for this program, please complete the evaluation
form and e-mail to [email protected].
You will be issued a CE certificate after a completed form is received.
Use of Automated Technology to Improve IV Room Operations and Reduce Medication Errors
Historically, manual IV compounding practices have left gaps for errors that compromise patient care and generate costly waste.
A recent study revealed that 7% of high risk IVs are compounded incorrectly.1 Join us for this educational session to learn more about improving IV compounding workflow and the need for adoption of proven technologies and best practices to optimize the safety and reliability of sterile
compounding.
Date: Thursday, March 1, 2018
Time: 2:00 p.m.
ET, 60 minutes
Speaker: Ruth E.
Cassidy, B.S.
PharmD, FACHE, Senior Vice President of Clinical Support Services, Chief Pharmacy Officer, SBH Health System, Bronx, NY
Peripheral IVs: Infection Risks, Evidence and Patient Satisfaction
There is a lot to consider when implementing an extended dwell time policy for inpatient peripheral intravenous lines.
During this webcast we will learn how a large, urban community hospital developed an education bundle and an insertion bundle that allowed for longer dwell times with a goal to decrease bloodstream infections.
Date: Tuesday, February 20, 2018
Time:
3:00pm ET, 60 minutes
Speaker: Michelle DeVries, MPH CIC, Senior Infection Control Officer, Methodist Hospitals
Join us for a Webinar Series on Enterprise Medication Management: Benefits and Risks
Mergers, acquisitions and divestitures of hospitals and clinics are driving the need for financial and process efficiencies. Managing the pharmacy as an enterprise is essential to the success of the pharmacy business and the health system. Learn what the pharmacy enterprise is, as well as the benefits and risks of implementing shared medication management services across the health system. The webinar series will cover how to integrate pharmacy services across a multihospital health system to help improve financial and clinical performance.
Enterprise Medication Management: The Basics
Date: October 25, 2017
Time: 2:00 p.m.
ET, 60 minutes
Speaker: Gina Lohr, MPP, Senior Consultant, The Advisory Board
Enterprise Medication Strategy: Shared Services, Shared Objectives for the Front Line
Date: December 12, 2017
Time: 2:00 p.m.
ET, 60 minutes
Speaker: Bonnie Levin, Pharm D, MBA, Assistant Vice President, Pharmacy Services, MedStar Health
Join us for a series of webinars focused on managing opioids in the acute care setting.
The abuse of prescription opioids has grown dramatically over the last 15 years, becoming one of the most serious public health problems in the United States. Opioids are overprescribed, resulting in nonmedical consumption and abuse, and often leading to the use of illicit forms of opiates such as heroin. The prescription opioid crisis costs our country an estimated $55 billion in health and social costs every year2 with devastating consequences to communities and families across the country. Acute care providers are on the front lines of this public health epidemic every day as a result of drug diversion, transitions of care from the hospital and the toll it takes on emergency departments.
We will discuss the healthcare systems’ responsibility to protect patients and staff from these highly dangerous drugs, the impact of federal and state regulations on the health system, and practical applications to deter and monitor opioid diversion in the acute care setting. Topics will also cover opioid safety and preventing opioid-related adverse events with capnography.
Drug Diversion in Healthcare Facilities: a Law Enforcement Perspective
Learn how to investigate drug diversion in an acute care facility from a law enforcement perspective.
Speaker: John Burke, President, International Health Facility Diversion
Association
Opioid Crisis, Healthcare Systems and Drug Diversion: Legal Mandates and Patient Safety Imperatives
Learn how diversion from health systems contributes to the opioid epidemic, and how to deal with regulatory agencies after a diversion event.
Speaker:
Chris Fortier, PharmD, Chief Pharmacy Officer, Massachusetts General Hospital, Boston, MA
Practical Applications to Manage Controlled Substances in Acute Care Settings
Take proactive steps to manage controlled substances.
Learn how to set policies and procedures to deter controlled substance diversion.
Speaker: Robert Fink, PharmD, MBA, FACHE, FASHP, BCNSP, BCPS, VP Ancillary Services and Chief Pharmacy Executive, Quorum Health
Reflections From an Early Adopter of Continuous Capnography Monitoring for Opioid Administration
St.
Joseph's/Candler initiated continuous capnography for all patient-controlled analgesia (PCA) patients in 2005.
This webinar explores the successes, expansion, roles and responsibilities of implementing continuous capnography, and provides lessons learned from the perspectives of nursing leadership, pharmacy and respiratory therapy.
Speaker: Harold Oglesby, RRT, Manager of Center for Pulmonary Health, St.
Joseph's/Candler
Continuing Education
Mitigating Risk of Extravasation with Power Injection
Speaker: Lynn Hadaway, M.Ed., RN-BC, CRNI
The incidence of extravasation of contrast media has increased since the introduction of power injection.
Published rates are low; however, the high number of estimated tomography procedures puts many patients at risk.
The outcomes for an individual patient can be devastating and long-lasting.
Learn best practices for what you can do to reduce the risk.
Changing the Safety Paradigm on IV Medication Use: Recognizing the Risk and Taking Action
Errors involving IV medications can result in significant patient harm, given the immediate bioavailability and narrow therapeutic index of many of the drugs used.
This activity will address the multi-factorial risks associated with IV medications, along with the need for proven safety technologies, practice innovation, and educational strategies to enhance safety in all phases of the medication use process.
Expert speakers will describe technologies available to support safe compounding and distribution practices with IV therapy, as well as the value of adopting barcoding technology and smart infusion pumps integrated with the electronic health record (EHR) to promote safe administration at
the bedside.
Planning for a Seamless Transition for Infusion Pump Integration With the EHR
The integration of smart infusion pumps with other technology such as computerized physician order entry (CPOE) and electronic health records (EHRs) is a huge step forward in
reducing pump programming errors and enhancing the safe administration of IV medications.
This continuing education (CE) activity will provide you with key information on how to prepare your organization for autoprogramming IV infusions and optimizing closed-loop technologies.
Invited Conferences
On March 7, 2017, a policy roundtable was held in Washington, D.C. focused on safe opioid use and the prevention of diversion in the acute care setting. Learn more about the approaches that were discussed.
White papers
White Paper on Controlled Substances Diversion
Guidelines
ASHP Guidelines on Preventing Diversion of Controlled Substances
Press releases
New BD Institute For Medication Management Excellence Aims To Improve Patient Safety And Outcomes Through Collaboration
BD Initiates New Industry Alliance To Combat Rising Opioid Crisis
Blogs
Control of opiate prescribing - solution or problem?
Opioid crisis and diversion
Healthcare's Dirty Little Secret
A persistent problem
Reference
1 Reece KM, Lozano MA, Roux R, Spivey SM.
Implementation and evaluation of a gravimetric I.V.
workflow software system in an oncology ambulatory care pharmacy.
Am J Health Syst Pharm.
2016;73(3):165–173.
2 Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL.
Societal costs of prescription opioid abuse, dependence, and misuse in the United States.
Pain Med. 2011;12(4):657–667.
doi: 10.1111/j.1526-4637.2011.01075.x.
BD is committed to keeping your personal data protected and secure. More information on how we protect your personal data can be found in our privacy statement and our cookie policy.